Evidence map›Paper›PMID 21078206›Full record

ArticleBMC molecular biology2010

A tryptophan-rich peptide acts as a transcription activation domain.

Chen-Huan Lin, Grace Lin, Chia-Pei Chang, Chien-Chia Wang

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Dynamic interplay ofFrontiers in plant science · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chen-Huan LinDepartment of Life Science, National Central University, Jung-li 32001, Taiwan.
Grace Lin
Chia-Pei Chang
Chien-Chia Wang
National Central University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEukaryotic transcription activators normally consist of a sequence-specific DNA-binding domain (DBD) and a transcription activation domain (AD). While many sequence patterns and motifs have been defined for DBDs, ADs do not share easily recognizable motifs or structures.

resultsWe report herein that the N-terminal domain of yeast valyl-tRNA synthetase can function as an AD when fused to a DNA-binding protein, LexA, and turn on reporter genes with distinct LexA-responsive promoters. The transcriptional activity was mainly attributed to a five-residue peptide, WYDWW, near the C-terminus of the N domain. Remarkably, the pentapeptide per se retained much of the transcriptional activity. Mutations which substituted tryptophan residues for both of the non-tryptophan residues in the pentapeptide (resulting in W5) significantly enhanced its activity (~1.8-fold), while mutations which substituted aromatic residues with alanine residues severely impaired its activity. Accordingly, a much more active peptide, pentatryptophan (W7), was produced, which elicited ~3-fold higher activity than that of the native pentapeptide and the N domain. Further study indicated that W7 mediates transcription activation through interacting with the general transcription factor, TFIIB.

conclusionsSince W7 shares no sequence homology or features with any known transcription activators, it may represent a novel class of AD.

Indexed as

Transcriptional ActivationAmino Acid SequenceAmino Acid SubstitutionDNA-Binding ProteinsFungal ProteinsMolecular Sequence DataMutationPeptidesProtein Structure, TertiaryRecombinant Fusion ProteinsRNA, Transfer, Amino AcylTranscription Factor TFIIBTryptophanYeastsDNA-Binding ProteinsFungal ProteinsPeptidesRecombinant Fusion ProteinsRNA, Transfer, Amino AcylTranscription Factor TFIIBTryptophan

Identifiers

PMID21078206
PMCPMC2992532
OpenAlexW2056376824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.